Ascentage Pharma Outlined its Global Innovation Strategy During Presentation at 44th Annual J.P. Morgan Healthcare Conference
Two commercialized hematology products, Olverembatinib and Lisaftoclax, drive dual-engine growth with strong…
BridgeBio Announces Commercial Progress, Program Updates, and 2026 Milestones at the 44th Annual J.P. Morgan Healthcare Conference
January 12, 2026 10:30 ET | Source: BridgeBio Pharma, Inc. - Preliminary unaudited…
Krystal Biotech Provides Business Update at 44th Annual J.P. Morgan Healthcare Conference
January 11, 2026 13:00 ET | Source: Krystal Biotech, Inc. Preliminary 4Q…
Ascendis Pharma Provides Business and Strategic Roadmap Update at 44th Annual J.P. Morgan Healthcare Conference
- Rapidly transforming into a leading global biopharma company January 09, 2026…
iRhythm Technologies to Present at the 44th Annual J.P. Morgan Healthcare Conference
December 29, 2025 16:30 ET | Source: iRhythm SAN FRANCISCO, Dec. 29,…
Mesa Labs to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026
December 18, 2025 19:00 ET | Source: Mesa Laboratories, Inc. LAKEWOOD, Colo.,…
Sanuwave to Participate in the 44th Annual J.P. Morgan Healthcare Conference
EDEN PRAIRIE, Minn., Dec. 10, 2025 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc.…
